Methylphenidate toxicosis in dogs: 128 cases (2001-2008)

Area of Science:

• Veterinary Toxicology
• Canine Pharmacology
• Drug Safety in Animals

Background:

• Methylphenidate hydrochloride (MPH) is a common stimulant medication.
• Accidental ingestion in dogs can lead to toxicosis.
• Understanding MPH toxicosis is crucial for veterinary emergency care.

Purpose of the Study:

• To identify clinical signs and outcomes of MPH toxicosis in dogs.
• To evaluate the impact of MPH dose and formulation on toxicosis severity.
• To describe the management strategies for MPH intoxication in canines.

Main Methods:

• A retrospective case series design was employed.
• Data from 128 dogs with MPH exposure or toxicosis were analyzed.
• Information on signalment, dose, clinical signs, treatment, and outcomes was extracted from an Animal Poison Control Center database.

Main Results:

• 84% of exposed dogs (107/128) exhibited clinical signs, including hyperactivity, tachycardia, vomiting, agitation, and hyperthermia.
• Clinical sign severity was not strongly correlated with MPH dose.
• Extended-release MPH formulations were associated with more severe and prolonged signs, with three fatalities.

Conclusions:

• Even small ingestions of methylphenidate hydrochloride can cause significant clinical signs in dogs.
• Veterinary monitoring and supportive care are essential for all cases of MPH exposure in dogs, irrespective of the ingested dose.
• Extended-release formulations pose a higher risk for severe outcomes in canine methylphenidate hydrochloride toxicosis.